|Day's range||0.77 - 0.83|
|52-week range||0.54 - 1.82|
|PE ratio (TTM)||-10.00|
|Dividend & yield||N/A (N/A)|
|1y target est||1.92|
Study on Efficacy of L-Dex® in Routine Clinical Practice Published Brisbane, Australia and Carlsbad, Calif., September 15, 2016 - ImpediMed Limited (ASX: IPD), a global provider of medical technology to ...
ImpediMed has been in a whirlwind of excitement over the launch of SOZO, the first product on ImpediMed's new population health platform for the future of health and wellness. SOZO is the world's first ...
SOZO™ Launched - First Product for Health and Wellness Markets Brisbane, Australia and Carlsbad, Calif., August 11, 2016 - ImpediMed Limited (ASX: IPD) announced today that SOZO™, the first product on ...